Ozempic Lawsuit in California (GLP-1 Claims)

What California residents should know

California residents with GLP-1 injury claims are generally not limited to California state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 3,763 pending cases as of June 1, 2026.

California law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.

California's Medi-Cal coverage change and the Ozempic litigation

California residents' federal GLP-1 injury cases are transferred into MDL-3094 in the U.S. District Court for the Eastern District of Pennsylvania for coordinated proceedings. On the coverage side, California's Medicaid program (Medi-Cal) ended coverage of GLP-1 medications such as Wegovy, Zepbound, and Saxenda for weight loss effective January 1, 2026, while coverage for diabetes and certain other approved indications continues. California Attorney General Rob Bonta also joined a February 2025 letter from more than three dozen state attorneys general urging the FDA to act against counterfeit and illegally compounded GLP-1 drugs.

Sources: Medi-Cal Rx — changes effective January 2026 (California DHCS); Multistate attorneys general letter to the FDA on GLP-1 drugs (Feb. 19, 2025).

Possible eligibility factors

• Documented use of a GLP-1 medication (prescription and pharmacy records from California providers).
• A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
• Injury timing consistent with medication use.
• Filing within the deadline that applies to the claim under California law.

How California claims proceed

Most California GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. The court has scheduled Rule 702 expert-admissibility hearings for September 10–18, 2026 (Case Management Order No. 32); bellwether trial dates have not yet been set. California's general personal injury limitations period is 2 years (Cal. Code Civ. Proc. § 335.1), but accrual and discovery-rule questions are fact-specific for injuries that develop during ongoing medication use.

What records support Ozempic claims in California?

• Prescription, pharmacy, insurance, or provider records showing Ozempic or another GLP-1 medication and dates of use.
• Emergency room, hospital, gastroenterology, imaging, gastric-emptying, surgery, or follow-up records for the alleged injury.
• Records showing diagnosis timing for gastroparesis, bowel obstruction, ileus, aspiration, or related complications.
• Medication history, dose changes, side-effect reports, provider messages, and documents that help connect use and symptoms.

What exposure and legal context matter in California?

California residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.

Where are California Ozempic cases handled?

Living in California does not necessarily mean the case will be filed only in California. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in California

• Northern District of California
• Eastern District of California
• Central District of California
• Southern District of California

What is the filing deadline for Ozempic lawsuits in California?

For a California resident researching Ozempic claims, the starting point is usually California's general personal injury period: 2 years under Cal. Code Civ. Proc. § 335.1. That is only a starting point, not a final legal deadline for every person.

The real filing deadline can depend on diagnosis date, when the injury and possible cause were discovered, exposure location, wrongful-death issues, prior claim paperwork, and whether the case is filed directly, transferred to an MDL, or handled through another process.

Discovery-rule note: California applies a discovery rule: the period generally runs from when a plaintiff discovers, or reasonably should have discovered, the injury and its wrongful cause.

How long do California residents have to file?

California's personal injury statute of limitations applicable to product liability claims is 2 years (Cal. Code Civ. Proc. § 335.1). Accrual timing, tolling, and repose periods can still change the real deadline in an individual case.

• Filing period: 2 years — Cal. Code Civ. Proc. § 335.1.
• Discovery rule: California applies a discovery rule: the period generally runs from when a plaintiff discovers, or reasonably should have discovered, the injury and its wrongful cause.

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

What should California residents ask a lawyer?

• Which GLP-1 medication and injury records do you need for an initial review?
• Do I need a gastric-emptying study, hospitalization record, imaging report, or specialist diagnosis?
• How do the Rule 702 schedule and lack of bellwether trial dates affect current claim review?
• How do state filing deadlines apply to my medication and symptom timeline?
• Would my claim be handled locally, nationally, or through the MDL?
• Are there upfront costs?